IPP Bureau
HUL funds study on Covid-19 vulnerability and vaccine efficiency
By IPP Bureau - September 07, 2021
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Max Ventilator forms partnership with US-based Amptron Medical
By IPP Bureau - September 07, 2021
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Anti-dumping duty proposed on Vitamin C from China for five years
By IPP Bureau - September 07, 2021
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
Brinton launches Hohner Health in India
By IPP Bureau - September 06, 2021
The focus is on wellness and personal care products
Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19
By IPP Bureau - September 06, 2021
Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence
TB Alliance partners with Lupin for non-exclusive anti-TB drug
By IPP Bureau - September 06, 2021
According to WHO, over 1.5 million people died of TB in 2020
Zydus Cadila’s Sitagliptin base tablets receive tentative approval from US FDA
By IPP Bureau - September 06, 2021
Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate)
CRAMS to drive growth for Indian pharma industry: report
By IPP Bureau - September 06, 2021
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
DGCI approves Hetero’s Tocilizumab
By IPP Bureau - September 06, 2021
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
Accutest enables NMPA approval for Qilu’s Abiraterone
By IPP Bureau - September 06, 2021
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
NF Healthcare launch latest version of its oxygen generators
By IPP Bureau - September 06, 2021
The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour
Alembic JV Aleor receives US FDA final approval for skin disorder gel
By IPP Bureau - September 06, 2021
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Govt revises NLEM and slashes prices of 39 drugs
By IPP Bureau - September 04, 2021
At present 18 per cent of the local pharmaceutical market is under government's price control
Reliance Strategic Business Ventures acquires Strand Life Sciences for Rs 393 crores
By IPP Bureau - September 04, 2021
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
HCG acquires oncology labs and divests stake in Strand Life Sciences
By IPP Bureau - September 04, 2021
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
